CDNA
HealthcareCaredx Inc
Live · NASDAQ · May 9, Close
What's Moving CDNA Today?
No stock-specific AI insight has been generated for CDNA yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
CDNA News
21 articles- A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum CoolsYahoo Finance·May 4, 2026
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance·May 1, 2026
- CareDx, Inc Q1 2026 Earnings Call SummaryMoby·Apr 29, 2026
- CareDx Inc (CDNA) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ExpansionYahoo Finance·Apr 29, 2026
- CareDx to Acquire Naveris to Expand Into Cancer MRD TestingYahoo Finance·Apr 29, 2026
- CareDx Q1 Earnings Call HighlightsMarketbeat·Apr 28, 2026
- CareDx (CDNA) Q1 2026 Earnings Call TranscriptMotley Fool·Apr 28, 2026
- CareDx (CDNA) Q1 Earnings and Revenues Top EstimatesYahoo Finance·Apr 28, 2026
- CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance TestingYahoo Finance·Apr 28, 2026
- CareDx Announces First Quarter 2026 Financial ResultsYahoo Finance·Apr 28, 2026
- CareDx (CDNA) Q2 2025 Earnings TranscriptMotley Fool·Apr 28, 2026
- High Growth Tech Stocks To Watch In US April 2026Yahoo Finance·Apr 24, 2026
- CareDx Announces Presentation of More Than 50 Abstracts Including 16 Oral Presentations at the International Society for Heart and Lung Transplantation’s 46th Annual MeetingYahoo Finance·Apr 21, 2026
- CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read SequencingYahoo Finance·Apr 20, 2026
- Assessing CareDx (CDNA) Valuation After Recent Share Price Momentum And Mixed Long Term ReturnsYahoo Finance·Apr 20, 2026
- All You Need to Know About CareDx (CDNA) Rating Upgrade to BuyYahoo Finance·Apr 17, 2026
- Are Medical Stocks Lagging CareCloud (CCLD) This Year?Yahoo Finance·Apr 17, 2026
- Why Diagnostics Names CareDx And QuidelOrtho Just DivergedYahoo Finance·Apr 16, 2026
- CareDx Sharpens Focus On Core Testing ServicesBenzinga·Apr 16, 2026
- CareDx Announces Agreement to Divest Lab Products Business to EuroBio Scientific for $170 Million and Announces First Quarter Preliminary Financial ResultsYahoo Finance·Apr 15, 2026
- How The CareDx (CDNA) Investment Story Is Shifting With New Targets And Policy RisksYahoo Finance·Apr 15, 2026
All 21 articles loaded
Price Data
Fundamentals
Trading
About Caredx Inc
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.